Impaired hypertension control in France: What the nephrologist needs to know

被引:0
|
作者
Rubin, Sebastien [1 ,2 ]
Boulestreau, Romain [3 ]
Couffinhal, Thierry [2 ,4 ]
Combe, Christian [1 ,5 ]
Girerd, Xavier [6 ]
机构
[1] CHU Bordeaux, Serv Nephrol Transplantat Renale Dialyse & Aphere, Hop Pellegrin, Pl Amelie Raba Leon, F-33076 Bordeaux, France
[2] Univ Bordeaux, Unite Inserm U1034, Bordeaux, France
[3] Hop Pau, Serv Cardiol & Hypertens Arterielle, 4 Blvd Hauter, F-64064 Pau, France
[4] CHU Bordeaux, Serv Cardiol, Hop Haut Leveque, Ave Magellan, F-33604 Pessac, France
[5] Univ Bordeaux, Unite Inserm, U1026 BioTis, Bordeaux, France
[6] Fdn Rech Hypertens Arterielle, 12 Rue Colonnes Trone, F-75012 Paris, France
来源
NEPHROLOGIE & THERAPEUTIQUE | 2020年 / 16卷 / 06期
关键词
Cardiovascular risk; Chronic kidney disease; Epidemiology; Hypertension; Prevention; BLOOD-PRESSURE CONTROL; TRIAL; RESTRICTION; COMBINATION; PROGRESSION; PREVALENCE; TARGETS; DISEASE; WOMEN; MEN;
D O I
10.1016/j.nephro.2020.10.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In France, 1 adult out of 3 is affected by hypertension and only 1 hypertensive out of 4 achieves blood pressure targets (<140/90 mmHg). This proportion is significantly better in similar countries (e.g. England, Germany, the USA). Nephrologists are particularly concerned since although more than 90 % of Chronic Kidney Disease (CKD) stages 3 and 4 patients are hypertensive, the CKD-REIN cohort shows that in France more than 1 out of 2 patients with CKD remains with a blood pressure above 140/90 mmHg. This report, based on the latest French studies and surveys, raises an important warning about the situation in France, discusses the main reasons for these results and offers some suggestions for improvement. Otherwise we risk a dramatic increase in the incidence of myocardial infarction, stroke, dependency and dementia in the coming years. (C) 2020 Societe francophone de nephrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:347 / 352
页数:6
相关论文
共 50 条
  • [31] Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know
    Piotti, Giovanni
    Cremaschi, Elena
    Maggiore, Umberto
    JOURNAL OF NEPHROLOGY, 2017, 30 (01) : 53 - 61
  • [32] Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know
    Giovanni Piotti
    Elena Cremaschi
    Umberto Maggiore
    Journal of Nephrology, 2017, 30 : 53 - 61
  • [33] What the Adult Nephrologist Should Know About Alport Syndrome
    Kashtan, Clifford E.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2022, 29 (03) : 225 - 230
  • [34] Staphylococcus aureus Infections in Hemodialysis: What a Nephrologist Should Know
    Vandecasteele, Stefaan J.
    Boelaert, Johan R.
    De Vriese, An S.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (08): : 1388 - 1400
  • [35] BUT WHAT NEEDS-TO KNOW?
    不详
    CONNAISSANCE DES ARTS, 2014, (730): : 50 - 50
  • [36] WHAT THE PUBLIC NEEDS TO KNOW
    TRAINER, J
    TECHNOLOGY REVIEW, 1981, 84 (01): : 8 - 8
  • [37] WHAT PHARMACIST NEEDS TO KNOW
    STEWART, RB
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1975, 9 (12): : 664 - 664
  • [38] What the pediatrician needs to know
    Buchanan, GR
    PEDIATRICS IN REVIEW, 2005, 26 (11) : 401 - 409
  • [39] WHAT A SYSTEMATIST NEEDS TO KNOW
    WARE, RB
    INFOSYSTEMS, 1978, 25 (08): : 93 - &
  • [40] What the teacher needs to know
    Marlow, Neil
    Johnson, Samantha
    ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (11) : 945 - 945